U.S. Diabetes Market Set to Surge 60% by 2031 Amid GLP-1 Innovations and CGM Expansion
VANCOUVER, BC, Feb. 24, 2025 /PRNewswire/ - A new U.S. diabetes market report provides essential insights into the rapid transformation of this market, fueled by breakthrough GLP-1 agonist drugs and